NO934881L - Benzotiazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav - Google Patents

Benzotiazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav

Info

Publication number
NO934881L
NO934881L NO934881A NO934881A NO934881L NO 934881 L NO934881 L NO 934881L NO 934881 A NO934881 A NO 934881A NO 934881 A NO934881 A NO 934881A NO 934881 L NO934881 L NO 934881L
Authority
NO
Norway
Prior art keywords
preparation
group
benzothiazole derivatives
general formula
benzothiazole
Prior art date
Application number
NO934881A
Other languages
English (en)
Other versions
NO934881D0 (no
Inventor
Mireille Sevrin
Claude Morel
Michel Mangane
Pascal George
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO934881D0 publication Critical patent/NO934881D0/no
Publication of NO934881L publication Critical patent/NO934881L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Weting (AREA)
  • Diffracting Gratings Or Hologram Optical Elements (AREA)

Abstract

2-tienylimidazo[2,l-b]benzotiazol-3-eddiksyrederivater med den generelle formel (I). hvori. Rx står for en hydroksygruppe, en C^-C-alkoksygruppe eller en aminogruppe med generell formel -NRRhvori Rog Ruavhengig av hverandre står for et hydrogenatom, en rettkjedet eller forgrenet C-C-alkylgruppe, eller en allylgruppe eller en metoksyetylgruppe, eller også står -NRRfor en heterocyklisk gruppe inneholdende 3 til 6 karbonatomer,. Y står for en tienylgruppe som eventuelt er substituert med en alkylgruppe, og. X står for et hydrogenatom eller halogenatom.Forbindelsene har terapeutisk anvendelse. Deres fremstilling er beskrevet.
NO934881A 1992-12-30 1993-12-29 Benzotiazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav NO934881L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9215889A FR2699921B1 (fr) 1992-12-30 1992-12-30 Dérivés d'acide 2-(thien-2-yl)imidazo[2,1-b]benzothiazole-3-acétique, leur préparation et leur application en thérapeutique.

Publications (2)

Publication Number Publication Date
NO934881D0 NO934881D0 (no) 1993-12-29
NO934881L true NO934881L (no) 1994-07-01

Family

ID=9437257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934881A NO934881L (no) 1992-12-30 1993-12-29 Benzotiazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav

Country Status (18)

Country Link
US (1) US5418248A (no)
EP (1) EP0605295A1 (no)
JP (1) JPH06234770A (no)
KR (1) KR0140846B1 (no)
CN (1) CN1036009C (no)
AU (1) AU666790B2 (no)
CA (1) CA2112555A1 (no)
CZ (1) CZ282959B6 (no)
FI (1) FI935915A (no)
FR (1) FR2699921B1 (no)
HU (1) HUT70409A (no)
IL (1) IL108225A (no)
NO (1) NO934881L (no)
NZ (1) NZ250579A (no)
PL (1) PL301680A1 (no)
SK (1) SK149393A3 (no)
TW (1) TW257764B (no)
ZA (1) ZA939760B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006724A1 (fr) * 1996-08-09 1998-02-19 Yamanouchi Pharmaceutical Co., Ltd. Agonistes du recepteur du glutamate metabotropique
EP2218464A1 (en) * 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) * 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
US4896863A (en) * 1988-05-26 1990-01-30 Tim Riplinger System having material dispensing and wind up device with guide
JP2726999B2 (ja) * 1988-06-22 1998-03-11 日研化学株式会社 イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
EP0524055A1 (fr) * 1991-07-19 1993-01-20 Synthelabo Dérivés d'imidazo[2,1-b]benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique
EP0884319B1 (en) * 1992-03-12 2004-05-06 SmithKline Beecham plc N- (1-nButyl-4-piperidyl)methyl -3,4-dihydro-2H- 1,3 oxazino 3,2-a indole-10-carboxamide or a pharmaceutically acceptable salt thereof

Also Published As

Publication number Publication date
IL108225A (en) 1997-04-15
KR940014415A (ko) 1994-07-18
JPH06234770A (ja) 1994-08-23
FI935915A0 (fi) 1993-12-29
NO934881D0 (no) 1993-12-29
ZA939760B (en) 1994-08-18
NZ250579A (en) 1995-07-26
CN1036009C (zh) 1997-10-01
CN1096029A (zh) 1994-12-07
FR2699921A1 (fr) 1994-07-01
EP0605295A1 (fr) 1994-07-06
CA2112555A1 (en) 1994-07-01
CZ282959B6 (cs) 1997-11-12
SK149393A3 (en) 1995-02-08
CZ291893A3 (en) 1994-07-13
PL301680A1 (en) 1994-07-11
AU666790B2 (en) 1996-02-22
HU9303785D0 (en) 1994-04-28
FR2699921B1 (fr) 1995-02-10
AU5276293A (en) 1994-07-14
KR0140846B1 (ko) 1998-06-15
IL108225A0 (en) 1994-04-12
TW257764B (no) 1995-09-21
US5418248A (en) 1995-05-23
HUT70409A (en) 1995-10-30
FI935915A (fi) 1994-07-01

Similar Documents

Publication Publication Date Title
DK0944617T3 (da) Krystaller af benzimidazolderivater og deres fremstilling
NO20072116L (no) Farmasoytiske forbindelser
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
AU572405B2 (en) Heterocyclic-substituted indole
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
NO20062370L (no) Amidderivater
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
DE60128343D1 (de) Pyrimidine verbindungen
MX9605156A (es) Inhibidor de angiogenesis.
DE69835877D1 (de) Trizyklische verbindungen
NZ505220A (en) Arylpiperazines having activity at the serotonin 1A receptor, processes for their preparation and intermediates
NO305515B1 (no) 5-amino-8-metyl-7-pyrrolidinylkinolin-3-karboksylsyrederivater og farmas°ytiske preparater inneholdende disse
NO994659L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
NO944933L (no) Fremgangsmåte for å inhibere sykdomstilstander i brystet
NO971687D0 (no) Diazepinoindoler som forsfodiesterase IV-inhibitorer
HUP0301695A2 (hu) Eljárás [(aril-acetil)-amino]-tiazolok előállítására
MXPA02011464A (es) Derivados 1,4-diazepan-2,5-diona y su uso como antagonistas del receptor de la nk-1.
DK1303514T3 (da) Fremgangsmåde til fremstilling af azacycloalkanoylaminothiazoler
NO934881L (no) Benzotiazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav
DK188183A (da) Thiomethylpyridinderivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
NO20006350L (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds